WebStrategic collaborations are at the core of our business, whether we out-license our PharmFilm® technology to reinvent medicines or in-license adjacent assets for development and commercialization. Aquestive … WebMay 6, 2024 · Stephanie Carrington-- Investor Relations Thank you, Operator. Good morning, and welcome to today's call to review Aquestive Therapeutics' results for the first quarter of 2024 and business ... classic carmex moisturising lip balm WebInvestors and analysts may participate in the conference call by dialing (866) 417-5886 from the U.S. and (409) 217-8235 internationally, followed by the conference ID: 8453318. ... WebMar 9, 2024 · To remind you, the Aquestive team will be discussing some non GAAP financial measures this morning as part of its review of fourth quarter and full year 2024 … ea public id names WebMar 24, 2024 · Investor Relations ... Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later stage ... WebAug 4, 2024 · The year-over-year change in adjusted EBITDA was driven by higher net loss, including severance costs. Non-GAAP adjusted EBITDA loss was $18 million for the six months ended June 30, 2024 ... ea public id names examples WebAquestive Therapeutics, Inc. (AQST) Q4 2024 Earnings Call Transcript Aquestive Therapeutics, Inc. (NASDAQ:NASDAQ:AQST) Q4 2024 Results Conference Call March 8, 2024 8:00 AM ETCompany ParticipantsBennett Watson - Westwicke, Investor RelationsDan Barber -...

WebAug 10, 2024 · Aquestive Therapeutics, Inc. (NASDAQ: AQST) is a pharmaceutical company advancing medicines to solve patients’ problems with current standards of care … WebMar 7, 2024 · Aquestive Therapeutics , which belongs to the Zacks Medical - Drugs industry, posted revenues of $10.68 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 7.57%. classic car morris minor convertible WebMar 9, 2024 · Operator. Good morning and welcome to the Aquestive Therapeutics Fourth Quarter and Full Year 2024 Conference Call. (Operator Instructions) As reminders this call is being recorded, and I turn the ... WebMay 4, 2024 · Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q1 2024 Results Conference Call May 4, 2024 8:00 AM ETCompany Participants. Bennett Watson - Investor Relations. Keith Kendall - Chief Executive Officer ... classic car motor trade insurance WebAug 26, 2024 · A replay of each webcast will be available for 90 days following the event. For more information, please visit investors.aquestive.com. About Aquestive Therapeutics Aquestive Therapeutics is a specialty pharmaceutical company that applies innovative technology to solve therapeutic problems and improve medicines for patients. ea public id names that aren't taken WebAug 2, 2024 · Aquestive Therapeutics (AQST) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to loss of $0.33 per share a year ago.

WebMar 9, 2024 · Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2024 Earnings Conference Call March 9, 2024 8:00 AM ET. Company Participants. Bennett Watson - Investor Relations. Keith Kendall - Chief Executive Officer ea public id names ideas WebAquestive Therapeutics Reports Fourth Quarter & Full Year 2024 Financial Results and Provides Business Update on Key 2024 Objectives. Pivotal study for AQST-109 … ea public id search